A False Case of Clozapine-Resistant Schizophrenia
João Paulo Maia‐de‐Oliveira(Universidade Federal do Rio Grande do Norte), Jaime E. C. Hallak(Universidade de Ribeirão Preto), Cristiano Chaves(Queen's University), Antônio Waldo Zuardi(Universidade de Ribeirão Preto), João P. Machado‐de‐Sousa(Universidade de São Paulo), V. Alexandre(Universidade de São Paulo), J.A.S. Crippa(National Council for Scientific and Technological Development), Américo Ceiki Sakamoto(Clinics Hospital of Ribeirão Preto), S. L. Morais(Universidade de São Paulo), Joel Porfírio Pinto(Universidade de São Paulo)
Cited by 3
Related Papers
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
|Brazilian Journal of Psychiatry|2015|484
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
|Journal of Clinical Psychopharmacology|2015|465